RAS oncogene-mediated deregulation of the transcriptome: From molecular signature to function

被引：8
|
作者：
Schaefer, Reinhold [1 ]
Sers, Christine [1 ]
机构：
[1] Charite Univ Med Berlin, Lab Mol Tumor Pathol, D-10117 Berlin, Germany
来源：
ADVANCES IN ENZYME REGULATION, VOL 51 | 2011年 / 51卷
关键词：
HUMAN CANCER-CELLS; COLORECTAL-CANCER; EPITHELIAL-CELLS; NKG2D LIGANDS; GENES; TRANSFORMATION; METHYLATION; EXPRESSION; PROTEINS; DNMT1;
D O I：
10.1016/j.advenzreg.2010.11.005
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：126 / 136
页数：11
相关论文
共 23 条
  • [1] SUPPRESSION OF RAS ONCOGENE-MEDIATED TRANSFORMATION
    SCHAFER, R
    REVIEWS OF PHYSIOLOGY BIOCHEMISTRY AND PHARMACOLOGY, VOL 124, 1994, 124 : 29 - 92
  • [2] Lysyl Oxidase Antagonizes RAS Oncogene-mediated Transformation
    Liu, S.
    Ha-Thi, M. C.
    Schaefer, R.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S76 - S76
  • [3] REVERSAL OF DIVERGENT DIFFERENTIATION BY RAS ONCOGENE-MEDIATED TRANSFORMATION
    PAN, J
    ROSKELLEY, CD
    LUUTHE, V
    ROJIANI, M
    AUERSPERG, N
    CANCER RESEARCH, 1992, 52 (15) : 4269 - 4272
  • [4] Ras Oncogene-Mediated Progressive Silencing of Extracellular Superoxide Dismutase in Tumorigenesis
    Cammarota, Francesca
    de Vita, Gabriella
    Salvatore, Marco
    Laukkanen, Mikko O.
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [5] Oncogene-mediated metabolic gene signature predicts breast cancer outcome
    Aslan, Merve
    Hsu, En-Chi
    Garcia-Marques, Fernando J.
    Bermudez, Abel
    Liu, Shiqin
    Shen, Michelle
    West, Meredith
    Zhang, Chiyuan Amy
    Rice, Meghan A.
    Brooks, James D.
    West, Robert
    Pitteri, Sharon J.
    Gyorffy, Balazs
    Stoyanova, Tanya
    NPJ BREAST CANCER, 2021, 7 (01)
  • [6] Oncogene-mediated metabolic gene signature predicts breast cancer outcome
    Merve Aslan
    En-Chi Hsu
    Fernando J. Garcia-Marques
    Abel Bermudez
    Shiqin Liu
    Michelle Shen
    Meredith West
    Chiyuan Amy Zhang
    Meghan A. Rice
    James D. Brooks
    Robert West
    Sharon J. Pitteri
    Balázs Győrffy
    Tanya Stoyanova
    npj Breast Cancer, 7
  • [7] Pan-omic profiling of RAS oncogene-mediated transformation and therapy resistance
    Kasack, K.
    Schaefer, R.
    Koch, H.
    Kuester, B.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S175 - S175
  • [8] The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis
    Koo, HM
    Gray-Goodrich, M
    Kohlhagen, G
    McWilliams, MJ
    Jeffers, M
    Vaigro-Wolff, A
    Alvord, WG
    Monks, A
    Paull, KD
    Pommier, Y
    Vande Woude, GF
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (03): : 236 - 244
  • [9] RESISTANCE OF MURINE LTA CELLS TO ONCOGENE-MEDIATED PROGRESSION FROM TUMORIGENIC TO METASTATIC PHENOTYPE
    TUCK, AB
    WILSON, SM
    CHAMBERS, AF
    ANTICANCER RESEARCH, 1990, 10 (06) : 1507 - 1514
  • [10] EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation
    Jiang, K
    Delarue, FL
    Sebti, SM
    ONCOGENE, 2004, 23 (05) : 1136 - 1145
123